Skip to main content
. 2020 Nov;21(11):3177–3183. doi: 10.31557/APJCP.2020.21.11.3177

Table 6.

Impact of TLR2 Arg753Gln and TLR4 (Thr399Ile & Asp299Gly) Genotype Variants Regarding Pneumonia among AML and ALL Patients

Genotypes AML
Relative risk in AML
Absence of pneumonia Presence of pneumonia OR 95%CI P value
(N=100) (N=20)
TLR2 Arg753Gln AA 57 15 1 - - R
AG 39 2 0.187 0.02 1.739 0.148
GG 4 3 3.75 0.293 47.99 0.309
A 153 32 0.98 0.299 3.215 0.973
G 47 8
TLR4 Thr399Ile CC 88 2 1 - - R
CT 8 16 66 6.03 722 0.001
TT 2 2 22 0.719 672.8 0.0765
C 188 20 9.4 2.708 32.62 <0.001
T 12 20
TLR4 Asp299Gly AA 84 5 1 - - R
AG 11 13 17.11 2.79 104.7 0.002
GG 5 2 7.33 0.356 150.7 0.196
A 179 23 6.5 1.85 22.8 0.003
G 21 17